Why the study?
Hyperglycaemia is an independent risk factor for cardiovascular diseases, prompting evaluation of the effect of HbA1c values on clinical outcomes in diabetic and non-diabetic patients following ACS.
Does elevated HbA1c impact clinical outcomes and coronary artery disease severity in patients with acute coronary syndrome?
Does elevated HbA1c impact clinical outcomes and coronary artery disease severity in patients with acute coronary syndrome?
Elevated HbA1c in patients with acute coronary syndrome is associated with more severe coronary artery disease and a higher risk of cardiogenic shock.
Coronary Artery Disease is the leading cause of death worldwide currently, resulting in around 7 million deaths per year and can rise by 40% around 2020. The prevalence of CAD and the incidence of ACS also are very high and occurs 5-10 years earlier among Indians. The overall cardiovascular mortality is predicted to have risen by 103% in men and 90% in women between 1985 and 2015. Hyperglycaemia is an independent risk factor for cardiovascular diseases. Therefore, we evaluated the effect of HbA1c values on clinical outcomes in diabetic and non-diabetic patients following acute coronary syndromes (ACS).
No takes yet. Share an insight, caveat, or question.
Rajuri et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: